Chapter 17. Recent Advancements in the Discovery and Development of Agents for the Treatment of Diabetes.
- 1 January 1995
- book chapter
- Published by Elsevier
- Vol. 30, 159-168
- https://doi.org/10.1016/s0065-7743(08)60930-6
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Toxicity Studies on One‐Year Treatment of Non‐Diabetic and Streptozotocin‐Diabetic Rats with Vanadyl SulphateBasic & Clinical Pharmacology & Toxicology, 1994
- Effect of CGRP antagonist, alpha-CGRP 8-37, on acid secretion in the dogDigestive Diseases and Sciences, 1994
- Selective amylin antagonist suppresses rise in plasma lactate after intravenous glucose in the ratFEBS Letters, 1994
- Clinical review 53: The endocrinology of vasoactive peptides: synthesis to functionJournal of Clinical Endocrinology & Metabolism, 1994
- Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.Journal of Clinical Investigation, 1993
- CGRP 8-37 blocks the inhibition of gastric emptying induced by intravenous injection of α-CGRP in ratsLife Sciences, 1993
- Tiron administration minimizes the toxicity of vanadate but not its insulin mimetic properties in diabetic ratsLife Sciences, 1992
- Studies on Antidiabetic Agents. X. Synthesis and Biological Activities of Pioglitazone and Related Compounds.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Studies on antidiabetic agents. II. Synthesis of 5-(4-(1-methylcyclohexylmethoxy)-benzyl)thiazolidine-2,4-dione (ADD-3878) and its derivatives.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Detection of oxovanadium(IV) and characterization of its ligand environment in subcellular fractions of the liver of rats treated with pentavalent vanadium(V)Biochemical and Biophysical Research Communications, 1980